Events

Rappel de Implantable cardioplegia

Selon Korean Food & Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à South Korea qui a été fabriqué par St. Jude Medical Cardiac Rhythm Management Division.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    155
  • Date
    2014-09-11
  • Pays de l'événement
    South Korea
  • Source de l'événement
    KFDA
  • URL de la source de l'événement
    https://emed.mfds.go.kr
  • Notes / Alertes
    Korean data is current through September 2018. All of the data comes from Korean Food & Drug Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and South Korea.
  • Notes supplémentaires dans les données
    No. 12-1247

Device

Implantable cardioplegia
  • Modèle / numéro de série
  • Dispositif implanté ?
    Yes
  • Description du dispositif
    An instrument used to remove an atrium or ventricular fibrillation by sending an electrical shock through the inserted electrode to the heart
  • Manufacturer
    St. Jude Medical Cardiac Rhythm Management Division

Manufacturer

St. Jude Medical Cardiac Rhythm Management Division
  • Adresse du fabricant
    Seoul, Korea 337
  • Société-mère du fabricant (2017)
    Abbott Laboratories
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    KFDA